BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37690343)

  • 1. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease.
    Libé R; Huillard O
    Cancer Treat Res Commun; 2023; 37():100759. PubMed ID: 37690343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical Carcinoma: A Clinician's Perspective.
    Elfiky A
    Surg Pathol Clin; 2015 Dec; 8(4):751-4. PubMed ID: 26612225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
    Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
    Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
    Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical carcinoma.
    Baudin E;
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adrenocortical carcinoma and its treatment].
    Tupikowski W; Bednarek-Tupikowska G; Florczak A
    Postepy Hig Med Dosw (Online); 2004 Feb; 58():27-36. PubMed ID: 15069374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on adrenocortical carcinoma management and future directions.
    Varghese J; Habra MA
    Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):208-214. PubMed ID: 28277340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Adrenocortical Carcinoma.
    Vaidya A; Nehs M; Kilbridge K
    Surg Pathol Clin; 2019 Dec; 12(4):997-1006. PubMed ID: 31672303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
    Elfiky AA; Krishnan Nair HK
    Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary management of adrenocortical carcinoma.
    Zini L; Porpiglia F; Fassnacht M
    Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
    Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
    Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric adrenocortical carcinoma.
    Ilanchezhian M; Varghese DG; Glod JW; Reilly KM; Widemann BC; Pommier Y; Kaplan RN; Del Rivero J
    Front Endocrinol (Lausanne); 2022; 13():961650. PubMed ID: 36387865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation therapies for adrenocortical carcinoma.
    Altieri B; Ronchi CL; Kroiss M; Fassnacht M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101434. PubMed ID: 32622829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical cancer treatment.
    Patalano A; Brancato V; Mantero F
    Horm Res; 2009 Jan; 71 Suppl 1():99-104. PubMed ID: 19153517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Adrenocortical Carcinoma.
    Jasim S; Habra MA
    Curr Oncol Rep; 2019 Feb; 21(3):20. PubMed ID: 30798468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status and Future Targeted Therapy in Adrenocortical Cancer.
    Alyateem G; Nilubol N
    Front Endocrinol (Lausanne); 2021; 12():613248. PubMed ID: 33732213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of adrenocortical carcinoma.
    Strosberg JR; Hammer GD; Doherty GM
    J Natl Compr Canc Netw; 2009 Jul; 7(7):752-8; quiz 759. PubMed ID: 19635227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: A single center experience.
    Bronswijk MJH; Laenen A; Bechter OE
    Neoplasma; 2020 Jan; 67(1):209-213. PubMed ID: 31777255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in the treatment of adrenocortical carcinomas].
    Ducry J; Berthold D; Pralong F
    Rev Med Suisse; 2012 Nov; 8(362):2181-4, 2186. PubMed ID: 23240320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives for mitotane treatment of adrenocortical carcinoma.
    Puglisi S; Calabrese A; Basile V; Pia A; Reimondo G; Perotti P; Terzolo M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101415. PubMed ID: 32179008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.